Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Preeti Sonam"'
Autor:
Dikshat Gopal Gupta, Neelam Varma, Shano Naseem, Man UpdeshSingh Sachdeva, Parveen Bose, Jogeshwar Binota, Ashish Kumar, Minakshi Gupta, Palak Rana, Preeti Sonam, Pankaj Malhotra, Amita Trehan, Alka Khadwal, Subhash Varma
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 1-12 (2022)
Objective: Based on the immunophenotype, acute lymphoblastic leukemia (ALL) can be categorized into B-cell or T-cell lineages. B-cell precursor ALL (BCP-ALL) cases show various genetic/molecular abnormalities, and varying frequencies of chimeric fusi
Externí odkaz:
https://doaj.org/article/74e17afc2cf747ed859c06ceebadd1e2
Autor:
Riju Rani Deka, Shano Naseem, Prateek Bhatia, Jogeshwar Binota, Preeti Sonam, Palak Rana, Pankaj Malhotra, Neelam Varma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:416-423
NPM1 and FLT3-ITD are frequently mutated genes in acute myeloid leukemia. We studied clinico-hematological profile and survival outcome of adult acute promyelocytic leukemia (APL) patients harboring these mutations.De novo APL cases (12 years), enrol
Autor:
Ashish Kumar, Dikshat Gopal Gupta, Alka Khadwal, Jogeshwar Binota, Pankaj Malhotra, Parveen Bose, Preeti Sonam, Shano Naseem, Palak Rana, Man Updesh Singh Sachdeva, Subhash Varma, Amita Trehan, Minakshi Gupta, Neelam Varma
Publikováno v:
Turkish Journal of Hematology. 39:1-12
Objective Based upon the immunophenotype, acute lymphoblastic leukaemia (ALL) can be categorized into B or T cell lineage (B-cell ALL or T-cell ALL). B-cell precursor ALL (BCP-ALL) cases show various genetic/molecular abnormalities and varying freque
Autor:
Subhash Varma, Pankaj Malhotra, Parveen Bose, Neelam Varma, Jogeshwar Binota, Dikshat Gopal Gupta, Alka Khadwal, Man Updesh Singh Sachdeva, Preeti Sonam, Ashish Kumar, Shano Naseem, Palak Rana, Minakshi Gupta, Amita Trehan
Publikováno v:
Leukemia & Lymphoma. 63:633-643
For the detection of BCR-ABL1-like ALL cases, two methodologies, specifically Gene expression profiling (GEP) or Next-generation targeted sequencing (NGS) and TaqMan based low-density (TLDA) card, are being used. NGS is very costly and TLDA is not wi
Autor:
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, Shano Naseem, Man Updesh Singh Sachdeva, Sreejesh Sreedharanunni, Jogeshwar Binota, Parveen Bose, Minakshi Gupta, Preeti Sonam, Palak Gupta, Pankaj Malhotra, Alka Khadwal, Amita Trehan, Subhash Varma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S191-S192
Autor:
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, Shano Naseem, Man Updesh Singh Sachdeva, Sreejesh Sreedharanunni, Jogeshwar Binota, Parveen Bose, Minakshi Gupta, Preeti Sonam, Palak Gupta, Pankaj Malhotra, Alka Khadwal, Amita Trehan, Subhash Varma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S120
Autor:
Shano Naseem, Palak Rana, Preeti Sonam, Alka Khadwal, Ashish Kumar, Man Updesh Singh Sachdeva, Dikshat Gopal Gupta, Subhash Varma, Neelam Varma, Minakshi Gupta, Jogeshwar Binota, Amita Trehan, Pankaj Malhotra, Parveen Bose
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S268-S269
Context: For the detection of BCR-ABL1-like ALL cases, two methodologies, specifically gene expression profiling (GEP) or next-generation targeted sequencing (NGS) with TaqMan based low-density (TLDA) card, are being used. NGS is very costly, and TLD
Autor:
Alka Khadwal, Preeti Sonam, Jogeshwar Binota, Ashok Kumar, Shano Naseem, Pankaj Malhotra, Palak Rana, Subhash Varma, Parveen Bose, Amita Trehan, Man Updesh Singh Sachdeva, Dikshat Gopal Gupta, Minakshi Gupta, Neelam Varma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S206
Autor:
Yogeshwar Binota, Sreejesh Sreedharanunni, Pankaj Malhotra, Subhash Varma, Parveen Bose, Preeti Sonam, Neelam Varma, Minakshi Gupta, Man Updesh Singh Sachdeva, Shano Naseem, Palak Rana, Dikshat Gopal Gupta
Publikováno v:
Blood. 136:13-14
Introduction A new provisional entity of "B-lymphoblastic leukaemia/lymphoma, BCR-ABL1-like" has been introduced in the 2017 revised edition of WHO classification of tumours of haematopoietic and lymphoid tissues. BCR-ABL1-like cases are negative for